A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Actuate Therapeutics Inc.
Amgen
Hutchmed
Rigel Pharmaceuticals
AstraZeneca
Servier
Ikena Oncology
Eli Lilly and Company
Aminex Therapeutics, Inc.
Blueprint Medicines Corporation
Deciphera Pharmaceuticals, LLC
Novartis
Five Prime Therapeutics, Inc.
Celgene
Shenzhen BinDeBio Ltd.
Polaris Group
Shenzhen BinDeBio Ltd.
Novartis
INSYS Therapeutics Inc
Envita Medical Center, Inc.
TransMolecular
Thallion Pharmaceuticals